JW Pharmaceutical Corporation

Overview

JW Pharmaceutical Corporation is a leading pharmaceutical company in South Korea that specializes in the development and manufacturing of innovative healthcare solutions. The company is dedicated to advancing human health through extensive research and development in a wide range of therapeutic areas.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances JW Pharmaceutical Corporation is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

JW Pharmaceutical Corporation holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PNB-THIENAMYCIN IMINEActive2009-10-19
• CILASTATIN ACIDActive2009-10-15

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JW Pharmaceutical Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.